PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 27219337-4 2016 UA treatment (6-9 h) strongly blocked the survival AKT/GSK3beta/beta-catenin signalling pathway, which led to a concomitant reduction of the anti-apoptotic proteins c-Myc and p21, altogether resulting in the activation of intrinsic apoptosis. ursolic acid 0-2 H3 histone pseudogene 16 Homo sapiens 175-178 27219337-5 2016 Interestingly, UA at low concentrations (10-15 muM) enhanced the antitumoral effects of DXR by up to 2-fold, while in parallel inhibiting DXR-induced AKT activation and p21 expression, two proteins implicated in antitumoral drug resistance and cell survival. ursolic acid 15-17 H3 histone pseudogene 16 Homo sapiens 169-172 34141150-6 2021 Ursolic acid treatment downregulated the gene expression of survival factors BCL-2, SURVIVIN, NFKB and SP1, while upregulated the growth-restricting genes BAX, P21 and P53. ursolic acid 0-12 H3 histone pseudogene 16 Homo sapiens 160-163